Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 12;408(1):144.
doi: 10.1007/s00423-023-02881-w.

Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm

Saneya Pandrowala  1 , Shraddha Patkar  1 , Mahesh Goel  2 , Darius Mirza  3 , S K Mathur  4
Affiliations

Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm

Saneya Pandrowala et al. Langenbecks Arch Surg. .

Abstract

Background: Hepatocellular carcinoma (HCC) accounts for the sixth most common cancer and ranks third in mortality worldwide with inhomogeneity in terms of resection for advanced-stage disease.

Methods: A systematic review of published literature using the PubMed, Medline, and Google Scholar databases from 1995 to 2020 was conducted to identify studies that reported outcomes of resection for solitary HCC > 10 cm, BCLC B/C, and multinodular HCC. Our aim was to assess overall survival for resection, identify poor prognostic factors, and to compare it to trans-arterial chemotherapy (TACE) where data was available.

Results: Eighty-nine articles were included after a complete database search in the systematic review as per our predefined criteria. Analysis revealed a 5-year overall survival of 33.5% for resection of HCC > 10 cm, 41.7% for BCLC B, 23.3% for BCLC C, and 36.6% for multinodular HCC. Peri-operative mortality ranged from 0 to 6.9%. Studies comparing resection versus TACE for BCLC B/C had a survival of 40% versus 17%, respectively.

Conclusion: Our systematic review justifies hepatic resection wherever feasible for hepatocellular carcinomas > 10 cm, BCLC B, BCLC C, and multinodular tumors. In addition, we identified and proposed an algorithm with five poor prognostic criteria in this group of patients who may benefit from adjuvant TACE.

Keywords: Barcelona clinic liver cancer B/C; Hepatocellular carcinoma; Resection; Survival; Systematic review.

PubMed Disclaimer

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
    1. Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329–338. https://doi.org/10.1055/s-2007-1007122 - DOI - PubMed
    1. Sapisochin G, Goldaracena N, Laurence JM, Dib M, Barbas A, Ghanekar A et al (2016) The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study. Hepatology 64(6):2077–2088. https://doi.org/10.1002/hep.28643 - DOI - PubMed
    1. Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Park MS et al (2012) Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma. Liver Int 32(7):1120–1127. https://doi.org/10.1111/j.1478-3231.2012.02811.x - DOI - PubMed
    1. Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M et al (2019) Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res 49(10):1109–1113. https://doi.org/10.1111/hepr.13411 - DOI - PubMed

Publication types

LinkOut - more resources